Abbott Laboratories (ABT) Capital Expenditures (QoQ) (2009 - 2026)
Analysis
Abbott Laboratories (ABT) Capital Expenditures (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.79 Bn | 179.19 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.38 Bn | 119.16 Bn | 1.96 Bn |
| 3 | Medtronic | 118.45 Bn | 109.63 Bn | 6.34 Bn |
| 4 | Stryker | 105.32 Bn | 101.84 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.71 Bn | 66.17 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.81 Bn | 45.56 Bn | 1.35 Bn |
| 7 | Alcon | 34.03 Bn | 32.58 Bn | 1.68 Bn |
| 8 | Dexcom | 32.35 Bn | 30.40 Bn | 830.00 Mn |
| 9 | Steris | 21.17 Bn | 20.68 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.56% |
| Mar 31, 2026 | -42.09% |
| Dec 31, 2025 | 38.91% |
| Sep 30, 2025 | -1.20% |
| Jun 30, 2025 | 3.72% |
| Mar 31, 2025 | -32.78% |
| Dec 31, 2024 | 29.50% |
| Sep 30, 2024 | 4.32% |
| Jun 30, 2024 | 33.92% |
| Mar 31, 2024 | -47.28% |
| Dec 31, 2023 | 34.82% |
| Sep 30, 2023 | 10.45% |
| Jun 30, 2023 | 33.42% |
| Mar 31, 2023 | -37.70% |
| Dec 31, 2022 | 30.62% |
| Sep 30, 2022 | 23.22% |
| Jun 30, 2022 | 18.07% |
| Mar 31, 2022 | -47.72% |
| Dec 31, 2021 | 33.19% |
| Sep 30, 2021 | 11.62% |